Registration Dossier

Toxicological information

Acute Toxicity: oral

Currently viewing:

Some information in this page has been claimed confidential.

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1985/07/11-1985/07/31
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: According to OECD 423 guideline. GLP
Justification for type of information:
A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
Cross-reference
Reason / purpose:
read-across: supporting information
Reference
Endpoint:
acute toxicity: oral
Type of information:
read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Study period:
1985/07/11-1985/07/31
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: According to OECD 423 guideline. GLP
Justification for type of information:
A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
Reason / purpose:
read-across source
Qualifier:
equivalent or similar to
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
yes
Remarks:
only one dose tested
GLP compliance:
yes
Test type:
fixed dose procedure
Limit test:
yes
Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Sex: Males (10); Females (10)
- Weight at study initiation: Males (130-135 g), Females (110-115 g)
- Housing: individual
- Acclimation period: 6d
Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
A single dose of BP83HF (5 ml/kg; converted to 4.15 g/kg) was administered by oral gavage. An additional group of 5 males and 5 females were sham - dosed and acted as controls.
Doses:
5 ml/kg (converted to 4.15 g/kg)
No. of animals per sex per dose:
Male (10), Female (10); total animals (20)
Control animals:
yes
Details on study design:
The acute oral toxicity of BP83HF was investigated in a group of 5 male and 5 female CD rats of the Sprague - Dawley strain. Each animal received a single oral dose of 5 ml/kg (converted to 4.15 g/kg) administered by gavage. An additional group of 5 males and 5 females were 'sham - dosed and acted as controls. The condition of all animals was observed over a 14 day period following dosing.
Statistics:
Differences between treated and control group mean values for bodyweight gains were analyzed by Student t-test. When individual variance ratios were significant (P < 0.05), Cochran's approximation was applied (Snedecor and Cochran, 1973) .
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 4 150 mg/kg bw
Remarks on result:
other: (converted from 5 mL/kg bw) no mortality noted
Mortality:
No mortality was observed in any of the animals treated with 5 ml/kg (converted to 4.15 g/kg) of BP83HF.
Clinical signs:
Transient staining of the urogenital region with test material was observed in all test rats within 24 hours of dosing. Slight flaking of the skin on the feet of these, first noted on Day 7, resolved in most animals prior to termination. During days 0-2, a slight reduction of bodyweight gain was recorded for treated male rats when compared with controls, although subsequent weight gain was normal. Females were not similarly affected.
Body weight:
All surviving animals showed an increase in body weight over their initial values at the end of the observation period.
Gross pathology:
Macroscopic post mortem examination of all animals killed at termination (Day 14) revealed no findings considered to be related to treatment. Although a haemorrhagic focus was seen in the fore-stomach of a female dosed with the test material, this lesion was minimal and was considered to be incidental to treatment with the test material.
Interpretation of results:
other: Not classified
Remarks:
Criteria used for interpretation of results: EU
Conclusions:
The LD50 for BP83HF following oral gavage was >5 ml/kg (converted to 4.15 g/kg). Classification as an oral toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
Executive summary:

The acute toxicity of BP83HF was evaluated in rats via oral gavage at a dose of 5 ml/kg bw(converted to 4.15 g/kg). Observations were made as to the nature, onset, severity, and duration of toxicological signs once per day for a total of 14 days. All animals survived the entire observational period and displayed a low incidence of clinical symptoms.  The animals displayed little or no abnormalities. The LD50 for BP83HF following oral gavage was >5 ml/kg (converted to 4.15 g/kg). Classification as an oral toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1985
Report Date:
1985

Materials and methods

Test guideline
Qualifier:
equivalent or similar to
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
yes
Remarks:
only one dose tested
GLP compliance:
yes
Test type:
fixed dose procedure
Limit test:
yes

Test material

Reference
Name:
Unnamed
Type:
Constituent

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Sex: Males (10); Females (10)
- Weight at study initiation: Males (130-135 g), Females (110-115 g)
- Housing: individual
- Acclimation period: 6d

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
A single dose of BP83HF (5 ml/kg; converted to 4.15 g/kg) was administered by oral gavage. An additional group of 5 males and 5 females were sham - dosed and acted as controls.
Doses:
5 ml/kg (converted to 4.15 g/kg)
No. of animals per sex per dose:
Male (10), Female (10); total animals (20)
Control animals:
yes
Details on study design:
The acute oral toxicity of BP83HF was investigated in a group of 5 male and 5 female CD rats of the Sprague - Dawley strain. Each animal received a single oral dose of 5 ml/kg (converted to 4.15 g/kg) administered by gavage. An additional group of 5 males and 5 females were 'sham - dosed and acted as controls. The condition of all animals was observed over a 14 day period following dosing.
Statistics:
Differences between treated and control group mean values for bodyweight gains were analyzed by Student t-test. When individual variance ratios were significant (P < 0.05), Cochran's approximation was applied (Snedecor and Cochran, 1973) .

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 4 150 mg/kg bw
Remarks on result:
other: (converted from 5 mL/kg bw) no mortality noted
Mortality:
No mortality was observed in any of the animals treated with 5 ml/kg (converted to 4.15 g/kg) of BP83HF.
Clinical signs:
Transient staining of the urogenital region with test material was observed in all test rats within 24 hours of dosing. Slight flaking of the skin on the feet of these, first noted on Day 7, resolved in most animals prior to termination. During days 0-2, a slight reduction of bodyweight gain was recorded for treated male rats when compared with controls, although subsequent weight gain was normal. Females were not similarly affected.
Body weight:
All surviving animals showed an increase in body weight over their initial values at the end of the observation period.
Gross pathology:
Macroscopic post mortem examination of all animals killed at termination (Day 14) revealed no findings considered to be related to treatment. Although a haemorrhagic focus was seen in the fore-stomach of a female dosed with the test material, this lesion was minimal and was considered to be incidental to treatment with the test material.

Applicant's summary and conclusion

Interpretation of results:
other: Not classified
Remarks:
Criteria used for interpretation of results: EU
Conclusions:
The LD50 for BP83HF following oral gavage was >5 ml/kg (converted to 4.15 g/kg). Classification as an oral toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.
Executive summary:

The acute toxicity of BP83HF was evaluated in rats via oral gavage at a dose of 5 ml/kg bw(converted to 4.15 g/kg). Observations were made as to the nature, onset, severity, and duration of toxicological signs once per day for a total of 14 days. All animals survived the entire observational period and displayed a low incidence of clinical symptoms.  The animals displayed little or no abnormalities. The LD50 for BP83HF following oral gavage was >5 ml/kg (converted to 4.15 g/kg). Classification as an oral toxicant is not warranted under the new Regulation (EC) 1272/2008 on classification, labeling and packaging of substances and mixtures (CLP) or under Directive 67/518/EEC for dangerous substances and Directive 1999/45/EC for preparations.